Taiwan Health Ministry approves Vemlidy for chronic hepatitis B

Gilead Sciences, Inc. has recently announced that with effect from 1 May 2019, Vemlidy (tenofovir alafenamide, TAF)...

April 30, 2019 | Tuesday | News
Avalue Technology launches IoT based healthcare solutions

Avalue Technology Inc.a global embedded solution provider, associate member of Intel® Internet of Things Soluti...

April 21, 2019 | Sunday | News
BioAtla , Himalaya Therapeutics to develop, market CAB Products in China

BioAtla ®, LLC, a global clinical-stage biotechnology company focused on the development of Conditionally Activ...

April 16, 2019 | Tuesday | News
VolitionRx extends clinical trial programme in lung cancer

VolitionRx Limited has announced that it has added to its extensive clinical trial program with the execution of a non-b...

April 9, 2019 | Tuesday | News
Health2Sync, CTBC Bank & Bitmark launch world's first diabetes data trust

Health2Sync, a leader in diabetes management, has partnered with CTBC Bank and Bitmark to establish the world's fir...

March 27, 2019 | Wednesday | News
Three research organizations acquire AAHRPP recognition

The Association for the Accreditation of Human Research Protection Programs (AAHRPP) has announced its first accreditati...

March 25, 2019 | Monday | News
TaiwanJ Pharma signs $26M deal with Newsoara Biopharma

TaiwanJ Pharmaceuticals has signed a $26 million contract with Newsoara Biopharma to license out its drug candidate JKB-...

March 11, 2019 | Monday | News
Foresee Pharma announces topline results of FP-001 LMIS in prostate cancer

Foresee Pharmaceuticals, a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange has announced tha...

February 22, 2019 | Friday | News
Link between GSL antigens and tumor survival in breast cancer found in a new research

A team led by Dr. Chi-Huey Wong, Distinguished Research Fellow, Academia Sinica in Taiwan, in collaboration with OBI sci...

February 19, 2019 | Tuesday | News
Foresee Pharma enters exclusive license agreement with Accord Healthcare

An exclusive license agreement for the commercialisation of Foresee Pharmaceutical's (6576.TWO) novel FP-001 program (le...

February 12, 2019 | Tuesday | News
TLC appoints George Spencer-Green as CMO

Taiwan Liposome Company, a clinical-stage specialty pharmaceutical company dedicated to the development and commercializ...

February 5, 2019 | Tuesday | News
Precision Therapeutics collaborates with Taiwanese distributor

US based Precision Therapeutics Inc. has announced that its Skyline Medical division, producer of the FDA-approved and C...

January 28, 2019 | Monday | News
TWi Biotech completes patient enrollment for treatment of Epidermolysis Bullosa

TWi Biotechnology (TWiB), a clinical stage biopharmaceutical company focused on development of novel products for rare d...

January 24, 2019 | Thursday | News
TaiwanJ Pharma announces new clinical results on AIH drug

TaiwanJ Pharmaceuticals, a specialty pharmaceutical company dedicated to the development and commercialization of small ...

January 22, 2019 | Tuesday | News
CellMax, Medigen partner for cell therapy clinical trials

CellMax Life, a US based diagnostics company with a proprietary technology to detect precancer and cancer cells in blood...

January 11, 2019 | Friday | News
TTA supports entrepreneur to connect with global startup ecosystem

Dr. Yu-Chin Hsu, Deputy Minister of Science and Technology of Taiwan, the opening of Taiwan Tech Arena (TTA) at Eureka P...

January 10, 2019 | Thursday | News
Tech meets Healthcare in Taiwan

Taiwan is known as the heart of the world’s tech supply chain, offering high-quality products in electronics. Now ...

January 7, 2019 | Monday | Analysis
Windtree Therapeutics and CVie Therapeutics Announce Merger to Create a Global Acute Care Company

Windtree Therapeutics, a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respirator...

January 2, 2019 | Wednesday | News